Loading...
Chemical structure of Istradefylline

GC11590

Istradefylline

Also listed as Istradefylline(KW-6002)

Istradefylline(KW-6002) is an adenosine A2A receptor antagonist· Istradefylline improves the motor dysfunction of Parkinson's disease patients by selectively antagonizing adenosine A2A receptors and regulating the indirect pathway of the basal ganglia· Istradefylline is mainly used to treat Parkinson's disease

ChemicalCAS155270-99-8MW384.43FormulaC20H24N4O4
CAS number
155270-99-8
Molecular weight
384.43
Formula
C20H24N4O4
Solubility
≥ 8·8mg/mL in DMSO with gentle warming
InChIKey
IQVRBWUUXZMOPW-PKNBQFBNSA-N
Catalogue number
GC11590
Brand
GLPBIO
Computed properties PubChem CID 5311037 · XLogP 2.5 · TPSA 76.9 Ų · H-bond donors 0
XLogP
2.5
TPSA
76.9 Ų
H-bond donors
0
H-bond acceptors
5
Rotatable bonds
6
Heavy atoms
28

SMILES CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C

Computed descriptors from PubChem (CID 5311037), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.